Thrombocytopenia in patients with dengue virus infection in the Brazilian Amazon

Platelets

Volumn 18, Issue 8, 2007, Pages 605-612

  Mourao M P G ^a,b,c,d   Lacerda, M V G ^a,b,c,d,e   Macedo, V O ^f   Santos, J B ^d  

^a Institute of Tropical Medicine of Amazonas   (Brazil)

^b UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^c UNIVERSIDADE NILTON LINS   (Brazil)

^d UNIVERSITY OF BRASILIA   (Brazil)

^e FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

^f NONE

Author keywords

Brazil; Dengue; Hemorrhage; Platelet count; Platelets; Thrombocytopenia

Indexed keywords

ALANINE AMINOTRANSFERASE; SERUM ALBUMIN;

ADULT; ARTICLE; BLEEDING; BLOOD VESSEL INJURY; BRAZIL; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DENGUE; DENGUE VIRUS; ECCHYMOSIS; EPIDEMIC; HEMATEMESIS; HOSPITAL ADMISSION; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TOURNIQUET; VIRUS ISOLATION;

ALANINE TRANSAMINASE; BRAZIL; CAPILLARY PERMEABILITY; DENGUE; DENGUE HEMORRHAGIC FEVER; DISEASE OUTBREAKS; HOSPITALS; HUMANS; LIVER DISEASES; PLATELET COUNT; SERUM ALBUMIN; THROMBOCYTOPENIA;

DENGUE VIRUS;

EID: 36549034327     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100701426604     Document Type: Article

References (51)

1. Gubler DJ. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? Comp Immunol Microbiol Infect Dis 2004;27:319-330.
2. Guzmán MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 2003;27:1-13.
3. Guzmán MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002;2:33-42.
4. PAHO. Dengue surveillance. Available from: http://www.paho.org/English/ AD/DPC/CD/dengue.htm (Accessed 15 February 2006).
5. Siqueira Jr JB, Martelli CMT, Coelho GE, Simplício ACR, Hatch DL. Dengue and dengue hemorrhagic fever, Brazil, 1981-2002. Emerg Infect Dis 2005;11:48-53.
6. Figueiredo RMP, Thatcher BD, Lima ML, Almeida TC, Alecrim WD, Guerra MVF. Exanthematous diseases and the first epidemic of dengue to occur in Manaus, Amazonas State, Brazil, during 1998-1999. Rev Soc Bras Med Trop 2004;37:476-479.
7. Mourão MPG, Lacerda MVG, Albuquerque BC, Sandoval JC, Figueiredo RMP, Pinto R, et al. Outbreak of dengue hemorrhagic fever in Manaus: Strategies of health assistance and outcome. Braz J Infect Dis 2001;5(Suppl. 2):S22.
8. Halstead SB. Dengue. Curr Opin Infect Dis 2002;15:471-476.
9. Srichaikul T, Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract Res Clin Haematol 2000;13:261-276.
10. Schexneider KI, Reedy EA. Thrombocytopenia in dengue fever. Curr Hematol Rep 2005;4:145-148.
11. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 1998;161:6338-6346.
12. Yang KD, Wang CL, Shaio MF. Production of cytokines and platelet activating factor in secondary dengue virus infections. J Infect Dis 1995;72:604-605.
13. Oishi K, Inoue S, Cinco MT, Dimaano EM, Alera MT, Alfon JA, et al. Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J Med Virol 2003;71:259-264.
14. Krishnamurti C, Kalayanarooj S, Cutting MA, Peat RA, Rothwell SW, Reid TJ, et al. Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 2001;65:840-847.
15. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999;179:755-762.
16. Mitrakul C, Poshyachinda M, Futrakul P, Sangkawibha N, Ahandrik S. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1977;26(5 Pt 1):975-984.
17. Saito M, Oishi K, Inoue S, Dimaano EM, Alera MT, Robles AM, et al. Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol 2004;138:299-303.
18. Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Wang ST, et al. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol 2001;63:143-149.
19. Lin SF, Liu HW, Chang CS, Yen JH, Chen TP. Hematological aspects of dengue fever. Gaoxiong Yi Xue Ke Xue Za Zhi 1989;5:12-16.
20. Mairuhu AT, Mac Gillavry MR, Setiati TE, Soemantri A, ten Cate H, Brandjes DP, Van Gorp EC. Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect Dis 2003;3:33-41.
21. Srichaikul T, Nimmannitya S, Sripaisarn T, Kamolsilpa M, Pulgate C. Platelet function during the acute phase of dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1989;20:19-25.
22. Martinez-Torres E. Dengue and hemorrhagic dengue: The clinical aspects. Salud Publica Mex 1995;37(Suppl):S29-44.
23. World Health Organization (WHO). Dengue hemorrhagic fever: Diagnosis, treatment, prevention and control. 2nd ed. Geneva: Publisher. 1997.
24. de Paula SO, Fonseca BA. Dengue: A review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis 2004;8:390-398.
25. Wiwanitkit V. Bleeding and other presentations in Thai patients with dengue infection. Clin Appl Thromb Hemost 2004;10:397-398.
26. Narayanan M, Aravind MA, Thilothammal N, Prema R, Sargunam CS, Ramamurty N. Dengue fever epidemic in Chennai-a study of clinical profile and outcome. Indian Pediatr 2002;39:1027-1033.
27. Wiwanitkit V, Manusvanich P. Can hematocrit and platelet determination on admission predict shock in hospitalized children with dengue hemorrhagic fever? A clinical observation from a small outbreak. Clin Appl Thromb Hemost 2004;10:65-67.
28. Lum LC, Goh AY, Chan PW, El-Amin AL, Lam SK. Risk factors for hemorrhage in severe dengue infections. J Pediatr 2002;140:629-631.
29. Gomber S, Ramachandran VG, Kumar S, Agarwal KN, Gupta P, Dewan DK. Hematological observations as diagnostic markers in dengue hemorrhagic fever-a reappraisal. Indian Pediatr 2001;38:477-481.
30. Méndez A, González G. Dengue haemorrhagic fever in children: Ten years of clinical experience. Biomédica 2003;23:180-193.
31. Montenegro D, Lacerda HR, Lira TM, Oliveira DS, Lima AA, Guimaraes MJ, Vasconcelos PG. Clinical and epidemiological aspects of the dengue epidemic in Recife, PE, 2002. Rev Soc Bras Med Trop 2006;39:9-13.
32. Witayathawornwong P. DHF in infants, late infants and older children: A comparative study. Southeast Asian J Trop Med Public Health 2005;36:896-900.
33. Diaz-Quijano FA, Villar-Centeno LA, Martinez-Vega RA. Complications associated to severe thrombocytopenia in patients with dengue. Rev Med Chil 2006;134:167-173.
34. Wichmann O, Hongsiriwon S, Bowonwatanuwong C, Chotivanich K, Sukthana Y, Pukrittayakamee S. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop Med Int Health 2004;9:1022-1029.
35. Diaz-Quijano FA, Martinez-Vega RA, Villar-Centeno LA. Early indicators of severity in dengue virus infection. Enferm Infecc Microbiol Clin 2005;23:529-532.
36. Wang S, He R, Patarapotikul J, Innis BL, Anderson R. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 1995;213:254-257.
37. Huang KJ, Li SY, Chen SC, Liu HS, Lin YS, Yeh TM, et al. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J Gen Virol 2000;81(Pt 9):2177-2182.
38. Krishnamurti C, Peat RA, Cutting MA, Rothwell SW. Platelet adhesion to dengue-2 virus-infected endothelial cells. Am J Trop Med Hyg 2002;66:435-441.
39. Halstead SB. Dengue: Hematologic aspects. Semin Hematol 1982;19:116-131.
40. Wiwanitkit V. The tourniquet test is still a good screening tool for dengue illness. Trop Doct 2005;35:127-128.
41. Norlijah O, Khamisah AN, Kamarul A, Paeds M, Mangalam S. Repeated tourniquet testing as a diagnostic tool in dengue infection. Med J Malaysia 2006;61:22-27.
42. Halstead SB. More dengue, more questions. Emerg Infect Dis 2005;11:740-741.
43. Phuong CX, Nhan NT, Kneen R, Thuy PT, van Thien C, Nga NT, et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the World Health Organization classification system helpful? Am J Trop Med Hyg 2004;70:172-179.
44. Wali JP, Biswas A, Aggarwal P, Wig N, Handa R. Validity of tourniquet test in dengue haemorrhagic fever. J Assoc Physicians India 1999;47:203-204.
45. Shivbalan S, Anandnathan K, Balasubramanian S, Datta M, Amalraj E. Predictors of spontaneous bleeding in Dengue. Indian J Pediatr 2004;71:33-36.
46. Shah I, Deshpande GC, Tardeja PN. Outbreak of dengue in Mumbai and predictive markers for dengue shock syndrome. J Trop Pediatr 2004;50:301-305.
47. Souza LJ, Alves JG, Nogueira RM, Gicovate Neto C, Bastos DA, Siqueira EW, et al. Aminotransferase changes and acute hepatitis in patients with dengue fever: Analysis of 1,585 cases. Braz J Infect Dis 2004;8:156-163.
48. Wiwanitkit V. Platelet CD61 might have an important role in causing hemorrhagic complication in dengue infection. Clin Appl Thromb Hemost 2005;11:112.
49. Kumar ND, Tomar V, Singh B, Kela K. Platelet transfusion practice during dengue fever epidemic. Indian J Pathol Microbiol 2000;43:55-60.
50. Lum LC, Abdel-Latif Mel A, Goh AY, Chan PW, Lam SK. Preventive transfusion in Dengue shock syndrome-is it necessary? J Pediatr 2003;143:682-684.
51. Chuansumrit A, Phimolthares V, Tardtong P, Tapaneya-Olarn C, Tapaneya-Olarn W, Kowsathit P, Chantarojsiri T. Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 2000;31:10-14.